Reshma Kewalramani, CEO & President at VERTEX PHARMACEUTICALS INC / MA (VRTX), bought 20,000 shares at $195.14 ($3.9M) on 2021-08-19, disclosed to the SEC on 2021-08-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $195.14 | 5,757 | $1.1M | 28.7% |
| 2 | $195.14 | 5,757 | $1.1M | 28.7% |
| 3 | $196.34 | 4,243 | $833K | 21.3% |
| 4 | $196.34 | 4,243 | $833K | 21.3% |
| Total | $195.65 avg | 20,000 | $3.9M | 100% |
| Filing → |
| VRTX | SELL | 2024-11-12 | $7.8M | — | Filing → |
| VRTX | SELL | 2024-08-01 | $7.7M | — | Filing → |
| VRTX | SELL | 2024-07-24 | $7.6M | — | Filing → |